Search
for
Sort by
Research 841–870 of 1000+
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- An Uncommon and Severe Clinical Case of Sarcoptes scabiei Infestation in a Cat
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Clinical overview of tinea infection in Ramadi, Iraq
- Reversible Vision Loss with pituitary microadenoma Following PRP Injection for Hair Growth,A Rare Case Report
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- Permanent Makeup Removal Severe Complication—Case Report and Proposal of the Protocol for Its Management
- Antinuclear Antibody Positivity in Patients With Hair Loss After COVID-19 Infection
- Hair loss after SARS-CoV2 Infection
- Acute Telogen Effluvium Related To COVID-19 Infection: A Review
- Cutaneous Findings of COVID-19 Infection Related with Length of Hospital Stay: A Prospective, Multicenter Study
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.
- Multimodal therapeutic approach for a severe case of kaposiform lymphangiomatosis from procedural interventions to targeted therapies
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Response to Li et al.’s “Therapeutic efficacy of platelet-rich plasma combining with microneedling and topical minoxidil in refractory severe androgenic alopecia”
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ
- Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- The clinical course and outcomes of SARS-CoV-2 virus infection in children: a 24-week follow-up study in Sulaimaniyah, Iraq
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Zinc deficiency associated with hypothyroidism: An overlooked cause of severe alopecia
- Efficient In Vivo Targeting of Epidermal Stem Cells by Early Gestational Intraamniotic Injection of Lentiviral Vector Driven by the Keratin 5 Promoter
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Body Representation in Patients with Severe Spinal Cord Injury: A Pilot Study on the Promising Role of Powered Exoskeleton for Gait Training
- New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study